EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure

Shinwan Kany, Johanna Skibowski, Claus-Heinrich Müller, Volker Geist, Jörn Schmitt, Feraydoon Niroomand, Birgit Hailer, Sven Pleger, Ibrahim Akin, Matthias Hochadel, Jochen Senges, Edith Lubos

Clinical Research in Cardiology · 2023

DOI: 10.1007/s00392-022-02151-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, 2023. Verfasst von Shinwan Kany und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University Heart and Vascular Center Hamburg-Eppendorf, Martinistraße 52, 20251, Hamburg, Germany. s.kany@uke.de. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Heart Valve Diseases, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients undergoing left atrial appendage (LAA) occlusion (LAAO) are multi-morbid, including mitral valve disease (MVD) which is associated with anatomic changes of the left atrium (LA). This study aims to identify how atrial myopathy in MVD influences outcomes in LAAO.

Methods

Atrial myopathy in MVD was defined as LA diameter > 45 mm (♀) and > 48 mm (♂) and existing MVD or history of surgical/interventional treatment. Patients were compared with controls from the prospective, multicentre LAArge registry of LAAO.

Results

A total of 528 patients (52 MVD, 476 no-MVD) were included. The MVD group was significantly more likely to be older (78.2 years vs 75.9 years, p = 0.036) and female (59.6% vs 37.8%, p = 0.002). Altered LA anatomy was observed in MVD with significantly larger LA diameter (53 mm vs. 48 mm, p < 0.001) and LAA Ostia [at 135° 23.0 mm (20.5, 26.0) vs 20.0 mm (18.0, 23.0), p = 0.002]. Implant success was high with 96.2% and 97.9%, respectively, without differences in severe complications (7.7% vs 4.6%, p = 0.31). One-year mortality (17.8% vs 11.5%, p = 0.19) and a combined outcome of death, stroke, and systemic embolism (20.3% vs 12.4%, p = 0.13) were not different. Independent predictors of the combined outcome were peripheral artery disease (HR 2.41, 95% CI 1.46–3.98, p < 0.001) and chronic kidney disease (HR 3.46, 95% CI 2.02–5.93, p < 0.001) but not MVD and atrial myopathy.

Conclusion

Patients with MVD present with altered LA anatomy with increased LA and LAA diameter. However, procedural success and safety in LAAO are not compromised. One-year mortality is numerically higher in patients with MVD but driven by comorbidities. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationHeart Valve DiseasesStrokeMuscular DiseasesHumansFemaleMitral ValveProspective StudiesHeart AtriaTreatment Outcome

Stichwörter der Autor:innen

Atrial fibrillationLeft atrial appendage occlusionMitral valve regurgitationSafety outcomes

Autor:innen und Institutionen

  • Division of Cardiology, University Heart and Vascular Center Hamburg-Eppendorf, Martinistraße 52, 20251, Hamburg, Germany. s.kany@uke.de.
  • Division of Cardiology, University Heart and Vascular Center Hamburg-Eppendorf, Martinistraße 52, 20251, Hamburg, Germany.
  • Division of Cardiology and Intensive Care, Klinikum Lüneburg, Lüneburg, Germany.
  • Division of Cardiology, Segeberger Kliniken, Bad Segeberg, Germany.
  • Division of Cardiology, University Hospital Giessen, Giessen, Germany.
  • Division of Cardiology, St. Josefskrankenhaus Heidelberg, Heidelberg, Germany.

Förderung

  • Universitätsklinikum Hamburg-Eppendorf (UKE)

Zitieren

APA

Kany, S., Skibowski, J., Müller, C. H., Geist, V., Schmitt, J., Niroomand, F., Hailer, B., Pleger, S., Akin, I., Hochadel, M., Senges, J., & Lubos, E. (2023). Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-022-02151-7

Vancouver

Kany S, Skibowski J, Müller CH, Geist V, Schmitt J, Niroomand F, et al. Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure. Clinical Research in Cardiology. 2023. doi:10.1007/s00392-022-02151-7

BibTeX
@article{Kany2023,
  author = {Kany, Shinwan and Skibowski, Johanna and Müller, Claus-Heinrich and Geist, Volker and Schmitt, Jörn and Niroomand, Feraydoon and Hailer, Birgit and Pleger, Sven and Akin, Ibrahim and Hochadel, Matthias and Senges, Jochen and Lubos, Edith},
  title = {Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure},
  journal = {Clinical Research in Cardiology},
  year = {2023},
  doi = {10.1007/s00392-022-02151-7}
}
Kostenlos starten →